NanoVision Diagnostics is commercializing a novel electro-optical cancer diagnostic system 1000 times more sensitive than an optical microscope.
This system is able to detect molecular changes in a standard biopsy slide.

NanoVision Diagnostics will offer its proprietary technology as a diagnostic service.


The NanoVision Diagnostics system assesses molecular changes in nuclear DNA from a standard biopsy slide. The genetic and epigenetic changes that induce cancer also change chromatin structure. NanoVision Diagnostics has developed a novel method of measuring changes in chromatin structure.  Chromatin structural changes have been shown to correlate with cancer in multiple clinical studies.

More About Our Technology
We provide high quality services


187 Northpointe Blvd, Freeport, PA 16229

Contact Us Today

If you want to know more about our services or are interested in working with us, please fill out the form.

For further information, please contact us at [email protected]

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.